Cancel

Obesity 2021: Current Clinical Management of a Chronic, Serious Disease

LEARNING OBJECTIVES At the end of the activity, participants will be able to: • Recognize obesity as a chronic, relapsing, serious disease warranting long-term management and early intervention to minimize disease burden and decrease associated morbidity and mortality. • Destigmatize obesity to initiate and enhance patient engagement. • Apply guideline-recommended care for screening, diagnosis, and individualized treatment of adults and others with obesity. • Incorporate practic...
Primary Care Education Consortium

Patient, Provider, and Caregiver Connection™: Collaborative Approaches to Chronic Kidney Disease Management in T2DM

Program Overview This video-based program is designed for health care professionals to explore the available treatments for diabetic kidney disease (DKD) through a unique perspective, putting the patient’s voice front and center. A patient will lend their expertise to this program by sharing their journey living with DKD. This online activity focuses on the complex disease pathophysiology of DKD, the diseases and complications directly related to DKD, and the efficacy and safety of therap...
Physicians’ Education Resource®, LLC.

Current Approaches to Managing Patients With Obesity: Considering Weight Loss, Comorbidities, Pharmacotherapy, and Complications

Target Audience This activity has been designed for clinicians interested in the management of patients with obesity. Specialties include primary care providers, cardiologists, endocrinologists, obstetricians/gynecologists, and rheumatologists. Program Overview Obesity continues to become more prevalent in the United States, and with it, patients’ health and quality of life are diminished by increased incidence of cardiovascular disease, cometabolic conditions, some cancers, and mood di...
Paradigm Medical Communications, LLC In partnership with the Obesity Medicine Association (OMA) and Obesity Action Coalition (OAC

New Targets, New Combinations, New Treatment Goals: Assessing Therapeutic Options to Personalize Care in Multiple Myeloma

Target Audience The target audience for this activity is hematologists and oncologists who treat patients with MM. Physicians, nurses, and other health care professionals interested in the treatment of MM are also invited to participate. Activity Overview Almost all patients with multiple myeloma (MM) eventually relapse with the disease course typically involving multiple relapses and remissions. Therapy selection for relapsed or refractory (R/R) MM is nuanced and affected by many var...
Physicians’ Education Resource®, LLC.

A Glimpse Into Future of Myeloma Patient Management

ACTIVITY DESCRIPTION In the last 18 years, oncology clinicians and patients have witnessed significant advances in multiple myeloma (MM) management, with the development of new strategies for establishing diagnosis, assessing prognosis, monitoring minimal residual disease (MRD), and delivering supportive care. In this time, 16 new drugs have been approved by the US Food and Drug Administration (FDA) for use in MM—including 10 in the last 6 years alone. The rapidity with which clinical data ...
Multiple Myeloma Research Foundation, RedMedEd, and Penn State College of Medicine

Community Practice Connections ®: New Targets, New Combinations, New Treatment Goals: Assessing Therapeutic Options to Personalize Care in Multiple Myeloma

Target Audience The target audience for this activity is hematologists and oncologists who treat patients with MM. Physicians, nurses, and other health care professionals interested in the treatment of MM are also invited to participate. Program Overview Nearly all patients with multiple myeloma (MM) eventually relapse with the disease course typically involving multiple relapses and remissions. Therapy selection for relapsed or refractory (R/R) MM is nuanced and affected by many variable...
Physicians’ Education Resource®, LLC

Ace the Case: 79-Year-Old Man With Lower Back Pain, Increasing Fatigue, and Right Rib Pain

This activity utilizes a case study to discuss treatment options for transplant-ineligible multiple myeloma (MM) patients.
Penn State College of Medicine

Ace the Case: 71-Year-Old Woman With IgG Lambda Multiple Myeloma at Third Relapse

This activity utilizes a case study to discuss treatment options for multiple myeloma (MM) patients who have relapsed from previous therapies.
Penn State College of Medicine

Ace the Case: Worsening Fatigue and Diarrhea in a 64-Year-Old Woman With IgA Lambda Multiple Myeloma

This activity utilizes a case study to discuss early detection and intervention of treatment-related adverse events in patients with multiple myeloma (MM).
Penn State College of Medicine

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map